Literature DB >> 10851251

FRAXA and FRAXE: the results of a five year survey.

S A Youings1, A Murray, N Dennis, S Ennis, C Lewis, N McKechnie, M Pound, A Sharrock, P Jacobs.   

Abstract

We report the results of a five year survey of FRAXA and FRAXE mutations among boys aged 5 to 18 with special educational needs (SEN) related to learning disability. We tested their mothers using the X chromosome not transmitted to the son as a control chromosome, and the X chromosome inherited by the son to provide information on stability of transmission. We tested 3738 boys and 2968 mothers and found 20 FRAXA and one FRAXE full mutations among the boys and none among the mothers. This gives an estimated prevalence of full mutations in males of 1 in 5530 for FRAXA and 1 in 23 423 for FRAXE. We found an excess of intermediate and premutation alleles for both FRAXA and FRAXE. For FRAXA this was significant at the 0.001 level but the excess for FRAXE was significant only at the 0.03 level. We conclude that the excess of intermediate and premutation sized alleles for FRAXA may well be a contributing factor to the boys' mental impairment, while that for FRAXE may be a chance finding. We studied approximately 3000 transmissions from mother to son and found five instabilities of FRAXA in the common or intermediate range and three instabilities of FRAXE in the intermediate range. Thus instabilities in trinucleotide repeat size for FRAXA and FRAXE are rare, especially among alleles in the common size range.

Entities:  

Mesh:

Year:  2000        PMID: 10851251      PMCID: PMC1734610          DOI: 10.1136/jmg.37.6.415

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  Fragile X genotype characterized by an unstable region of DNA.

Authors:  S Yu; M Pritchard; E Kremer; M Lynch; J Nancarrow; E Baker; K Holman; J C Mulley; S T Warren; D Schlessinger
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

2.  Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group.

Authors:  B B de Vries; S Mohkamsing; A M van den Ouweland; E Mol; K Gelsema; M van Rijn; A Tibben; D J Halley; H J Duivenvoorden; B A Oostra; M F Niermeijer
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

3.  Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data.

Authors:  D J Allingham-Hawkins; R Babul-Hirji; D Chitayat; J J Holden; K T Yang; C Lee; R Hudson; H Gorwill; S L Nolin; A Glicksman; E C Jenkins; W T Brown; P N Howard-Peebles; C Becchi; E Cummings; L Fallon; S Seitz; S H Black; A M Vianna-Morgante; S S Costa; P A Otto; R C Mingroni-Netto; A Murray; J Webb; F Vieri
Journal:  Am J Med Genet       Date:  1999-04-02

4.  Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.

Authors:  P C Patsalis; C Sismani; J A Hettinger; I Boumba; I Georgiou; G Stylianidou; V Anastasiadou; R Koukoulli; G Pagoulatos; M Syrrou
Journal:  Am J Med Genet       Date:  1999-05-28

5.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

Authors:  A J Verkerk; M Pieretti; J S Sutcliffe; Y H Fu; D P Kuhl; A Pizzuti; O Reiner; S Richards; M F Victoria; F P Zhang
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

6.  The frequency of the fragile X chromosome among schoolchildren in Coventry.

Authors:  T P Webb; S Bundey; A Thake; J Todd
Journal:  J Med Genet       Date:  1986-10       Impact factor: 6.318

7.  Population studies of the fragile X: a molecular approach.

Authors:  P A Jacobs; H Bullman; J Macpherson; S Youings; V Rooney; A Watson; N R Dennis
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

8.  Preventive screening for the fragile X syndrome.

Authors:  G Turner; H Robinson; S Laing; S Purvis-Smith
Journal:  N Engl J Med       Date:  1986-09-04       Impact factor: 91.245

9.  Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation.

Authors:  F Rousseau; D Heitz; V Biancalana; S Blumenfeld; C Kretz; J Boué; N Tommerup; C Van Der Hagen; C DeLozier-Blanchet; M F Croquette
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

10.  A cytogenetic survey of 14,069 newborn infants. I. Incidence of chromosome abnormalities.

Authors:  J L Hamerton; N Canning; M Ray; S Smith
Journal:  Clin Genet       Date:  1975-10       Impact factor: 4.438

View more
  35 in total

Review 1.  Genetic effects on human cognition: lessons from the study of mental retardation syndromes.

Authors:  P Nokelainen; J Flint
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

2.  Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia.

Authors:  James Macpherson; Andrew Waghorn; Simon Hammans; Patricia Jacobs
Journal:  Hum Genet       Date:  2003-02-27       Impact factor: 4.132

3.  Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure.

Authors:  Claire E Bennett; Gerard S Conway; James N Macpherson; Patricia A Jacobs; Anna Murray
Journal:  Hum Reprod       Date:  2010-03-13       Impact factor: 6.918

4.  Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers.

Authors:  Sarah Ennis; Daniel Ward; Anna Murray
Journal:  Eur J Hum Genet       Date:  2006-02       Impact factor: 4.246

5.  Mapping of an origin of DNA replication in the promoter of fragile X gene FMR1.

Authors:  Bruna P Brylawski; Paul D Chastain; Stephanie M Cohen; Marila Cordeiro-Stone; David G Kaufman
Journal:  Exp Mol Pathol       Date:  2006-12-28       Impact factor: 3.362

6.  Most Martin-Bell syndrome (FMR1-related disorder) Venezuelan patients did not show CGG expansion but instead display genetic heterogeneity.

Authors:  Yasser Vega; Sergio Arias; Irene Paradisi
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

7.  Closely linked cis-acting modifier of expansion of the CGG repeat in high risk FMR1 haplotypes.

Authors:  S Ennis; A Murray; G Brightwell; N E Morton; P A Jacobs
Journal:  Hum Mutat       Date:  2007-12       Impact factor: 4.878

8.  Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice.

Authors:  Brian M Wilson; Charles L Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-07       Impact factor: 11.205

9.  A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.

Authors:  Flora Tassone; Ruiqin Pan; Khaled Amiri; Annette K Taylor; Paul J Hagerman
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

10.  Linking the FMR1 alleles with small CGG expansions with neurodevelopmental disorders: preliminary data suggest an involvement of epigenetic mechanisms.

Authors:  Danuta Z Loesch; David E Godler; Mahmoud Khaniani; Emma Gould; Freya Gehling; Cheryl Dissanayake; Trent Burgess; Flora Tassone; Richard Huggins; Howard Slater; K H Andy Choo
Journal:  Am J Med Genet A       Date:  2009-10       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.